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Drosophila melanogaster is a widely used, dynamic model organism to study 
various pathogenic diseases observed ubiquitously in the human population. 
Drosophila, at present, is extensively used to conduct preclinical studies besides 
its counterpart rodents. The epidemic and pandemic diseases are discussed in 
this review to demonstrate Drosophila melanogaster as a key model. Epidemic and 
pandemic diseases are still claiming more than 5 million lives every year, and these 
diseases were well studied in flies. Currently there is no cure for the disease like 
HIV; the bacterial and fungal infections usually seen in HIV/AIDS patients could 
be demonstrated elaborately in Drosophila melanogaster. Diseases like myocardial 
infractions and cancer causing viral infection are long term effects of ART (anti-
retroviral therapy) that could be experimented in flies. Stable Drosophila S2 cell 
line, Transgenic flies, transfusion of bacteria and fungi could be implemented to 
study several infectious diseases and for vaccine development. The latest trends 
in understanding pathogenic diseases and its potential biochemical markers in 
flies are discussed in this review to utilize the fruit flies as a functional tool and to 
explore further it in drug development. The advantages and disadvantages of the fly 
as a model of infection are discussed along with the epidemiology and the cellular 
pathophysiology
Keywords: Drosophila melanogaster, HIV, Influenza, cholera, tuberculosis, 
pneumonia, viral diseases, epidemic and pandemic diseases
1. Introduction
1.1 Epidemic disease
The term epidemic is derived from Greek word “epi” meaning “upon” and 
“demos” meaning “people”. It refers to a communicable disease which spreads rap-
idly in a given population within a very short period of time. Any infectious disease 
existing in a region does not make it epidemic unless it causes faster mortality. A 
death rate of around 1.6 folds higher than usual death rate (baseline) caused by a 
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disease in a population within a fixed period could be considered as an epidemic 
disease. A disease lower than this fold increase, observed in a population could be 
designated as an outbreak of a disease [1].
Diseases like tuberculosis, hepatitis, yellow fever, chikungunya, ebola virus 
disease, marburg virus disease, Crimean-Congo haemorrhagic fever, rift valley 
fever, typhoid fever, Shigellosis, plague, lassa fever, West Nile fever, zika virus dis-
ease, meningitis, MERS-CoV, plague, monkeypox, nodding syndrome, nipah virus 
infection are considered as epidemic diseases as per World Health Organization [2]. 
Epidemic diseases like plague, small pox and cholera caused unsurpassed deaths in 
human population till the end of eighteenth century [3].
1.2 Pandemic disease
The term pandemic is derived from Greek word “pan” meaning “all” and 
“demos” meaning “people”. It refers to an epidemic disease which spreads among 
large population possibly across geographic locations or continents within a short 
time span [4].
Influenza, along with viral pneumonia, HIV and cholera are considered as 
pandemic disease and caused millions to die beside high rate of hospitalization and 
life threatening conditions across the globe [2]. The viral diseases like Influenza, 
cholera and HIV caused maximum deaths in the twenty-first century [3].
1.3 Vaccination
Vaccines are available for most of the epidemic and pandemic diseases [5]. 
Vaccination is the most effective prevention technique to suppress the infection in 
healthy population [6]. However, poor and conflicted regions of Asia and Africa 
are deprived of these vaccines [7]. World Health Organization plays a major role in 
epidemic preparedness in these regions and provides extended healthcare facilities 
during an epidemic outbreak [8].
1.4 Global requirement
Considering, the disease outbreak and its transmission is high in a poor 
population of developing region [9]. First line and second line antibiotics are 
the most effective medicines for infected subjects as the vaccines are ineffective 
after the infection had taken place. First line therapy includes antibiotics are the 
most commonly prescribed medicines to alleviate the infection process, often 
not responsive on several types of multi drug resistant infection [10]. Hence it 
is important to select a cost effective model to screen the first line antibiotics or 
antivirals.
1.5 Fruit fly as a model organism for drug screening
Today, we need to discover more efficacious antibiotics to fight the infectious 
diseases. Drosophila melanogaster could be a useful model organism to study the 
infection process and to screen an efficient drug. Due to its shorter lifespan and vast 
genetic similarity towards vertebrates allows conducting the drug screening experi-
ments. It is reviewed here that Drosophila melanogaster was already been used to 
study infections caused by pandemic and epidemic diseases. But how to utilize the 
fruit flies to study different infectious disease and techniques to screen a potential 
drug candidate were not well reviewed.
3
Drosophila melanogaster: A Robust Tool to Study Candidate Drug against Epidemic…
DOI: http://dx.doi.org/10.5772/intechopen.90073
2. Epidemiology of infectious diseases
2.1 Lower respiratory tract infection epidemiology
As per World Health Organization lower respiratory tract infections are caused 
mainly by influenza, pneumococcal pneumonia and viral pneumonia are respon-
sible for 3 million deaths [11]. The WHO reported in 2018, 3–5 million cases of 
Influenza with 290,000–650,000 death cases annually [12]. As per the Global 
Disease burden (GDB) study report of 2015 there were around 1.5 million deaths 
in all age groups caused due to pneumococcal pneumonia [13]. SARS (Corona 
virus) causes viral pneumonia; it is epidemic to more than 30 countries with 8000 
reported cases and 774 deaths during the year 2002–2003. MERS is a viral pneu-
monia causing infections in 688 persons and 282 deaths reported by WHO in 20 
countries during 2012 [14].
2.2 Influenza
Influenza originates from Orthomyxoviridae family it can be differentiated into 
three types Influenza pandemic caused by Influenza A/B virus, seasonal Influenza 
and avian influenza (H5N1) [15]. Influenza virus causes upper respiratory tract 
infection often found to cause lower respiratory tract infection in association with 
bacterial co-invasion. The seasonal influenza leads to maximum hospitalization 
resulting fatality in infants during the seasonal outbreak [16].
2.3 Pneumonia and viral pneumonia
Pneumonia is caused due to several communicable infections usually known 
as community acquired pneumonia (CAP), often seen in hospitalized patients. 
Pneumonia can be caused by bacteria like Streptococcus pneumoniae, Haemophilus 
influenzae type b (Hib), and Chlamydia pneumoniae, Staphylococcus aureus, Klebsiella 
pneumonia and Mycoplasma pneumonia. Viruses like syncytial virus, adenovirus, 
rhinovirus, metapneumovirus, Influenza A/B viruses, Coronaviruses, parain-
fluenza virus including MERS and SARS causes viral pneumonia [17]. The viral 
pneumonia is the influenza often associated with bacterial infection thereby caus-
ing fatality better known as superinfection [18].
2.4 Tuberculosis
Tuberculosis is caused by Mycobacterium tuberculosis, a gram negative faculta-
tive anaerobic bacteria. In 2017 around 10 million people were infected with 
tuberculosis causing mycobacterium killing 1.6 million peoples across the world 
[19]. The current estimate of tuberculosis is not significantly different from the 
2015 WHO report [20].
2.5 HIV
Currently HIV is the most fatal disease observed in human population across the 
globe. It caused maximum number of deaths around the world in the last 3 decades. 
As per the latest WHO report of 2019, HIV/AIDS have claimed more than 35 million 
deaths till date. Currently 36.9 million (31.1–43.9 million) peoples are living with 
HIV as of 2017 [21]. Although the rate of infection has decreased in the recent years, 
still HIV remains a global burden on world economy.




The term “cholera” was derived from Sanskrit meaning “stomach disturbance” 
[22]. Since, early 1800 century cholera outbreak turned out to be pandemic and caused 
millions to die, altogether six different pandemics took place the seventh started in the 
year 1961 and is still ongoing [23, 24]. In 2019 WHO report suggests 1.3 million to 4.0 
million cases of cholera with an estimated 21,000–143,000 deaths worldwide [25].
2.7 Hepatitis
Viral hepatitis is one of the most life threatening disease, it causes death to 1.4 
million peoples across the globe reported in 2018 [26]. Globally around 260 million 
peoples are infected with HBV and 71 million with HCV infections are reported 
causing 90% of deaths among viral hepatitis patients [27]. The HBV and HCV has 
the highest prevalence rate in the global population at present, hepatitis viruses 
like HAV, HAD and HEV are endemic in many countries [26]. Currently there is no 
vaccine available for HCV till date.
2.8 Typhoid
The term Typhoid was coined from the Greek word “typhus” which means 
“Smoky” was used to relate the delirium symptom often associated with typhoid fever 
[28]. Typhoid fever is caused by gram-negative bacteria known as Salmonella enterica 
serovar typhi. Around 11–21 million cases of typhoid fever outbreak are reported annu-
ally, among that it causes death of 128,000–161,000 individuals worldwide [29].
2.9 Malaria
Malaria fever is a severe parasitic disease caused by Plasmodium falciparum and 
Plasmodium vivax transmits through female Anopheles gambiae mosquitoes. In the 
year 2017 219 million cases were noted by World Health Organization, this seasonal 
outbreak of malaria in 87 countries led to 435,000 deaths [30].
2.10 Viral meningitis, viral encephalitis and hemorrhagic fever viruses
Viruses like herpes simplex virus HSV, HIV, mumps virus, measles virus and 
west Nile virus causes meningitis which causes frequent outbreaks in some regions 
[31]. Japanese encephalitis virus along with genus Alphavirus Togaviridae fam-
ily viruses are arbovirus (arthropod borne virus) like California encephalitis, 
Chikungunya, dengue, Eastern equine encephalitis, Powassan, St. Louis encepha-
litis, Sindbis virus, West Nile, Yellow Fever and Zika virus are capable of causing 
encephalitis in humans [32, 33]. The viruses capable of causing hemorrhagic fever 
are dengue virus, rift valley virus, yellow virus, Crimean-Congo Hemorrhagic 
Fever, Lassa virus, Marburg virus and Ebola virus are epidemic diseases [34].
3. Drosophila model to study highly infectious diseases
There are at present several bacterial, fungal and viral models of infection 
which were successfully demonstrated to infect flies and used it to understand 
drug efficacy. Drosophila model of infectious disease could be very low cost model 
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to study drug efficacy in-vivo; it could help to save lives by saving time during an 
epidemic outbreak. Understanding the disease pathogenesis in humans and draw-
ing out a similar model in Drosophila melanogaster would suggest the target genes 
and proteins responsible for the underlying disease [35].
In the recent past several research works has been conducted to understand 
the immune system of Drosophila melanogaster. At present the immune system of 
Drosophila is a well-studied model to study infectious disease [35]. Adult flies have 
brain, heart, lung (spiracle), liver (fat body), kidney (renal tubule), GI tract (gut/
crop), ovary/testis and versatile circulatory system (hemocyte) [36]. Apart from 
physiological resemblance Drosophila has 75% genetical similarity with human 
disease genes, due to this fact genetically tractable model could be generated to 
what extent is discussed here [35].
4. Host-pathogen interaction
Drosophila melanogaster has a well-built immune system to withstand pathogenic 
incursion, comprising of cellular, humoral and innate immunity in an effective 
but in simpler form than humans [37]. However, due to evolutionarily conserved 
immune pathways found in vertebrates and invertebrates, several components of 
fly immune system are homologous to humans [38]. The immune activation in flies 
against pathogens involves processes like recognition, coagulation, melanisation, 
phagocytosis, apoptosis, regulation of iron metabolism, synthesis of antimicrobial 
peptides and production of reactive oxygen species [39].
The bacterial and fungal infection leads to the activation of dToll, Imd, Eiger 
(TNF family homolog) and insulin like receptors (FOXO) in Drosophila. The 
drosophila toll and Imd (immune deficiency) pathways function as innate immu-
nity. Toll receptors in flies play an important part during viral, fungal and bacte-
rial infection. The patterns recognition receptors (PRRs) initiate the signal in fly 
immune system depending on the type of pathogen upon interaction [40]. Gram 
positive and gram negative bacterial infection activates peptidoglycan recognition 
protein SA (PGRP-SA) and Gram-negative binding protein 1 (GNBP1) respectively. 
PGRP-SA causes proteolytic cleavage of Spatzle upon stimulation of dToll, it medi-
ates downstream signalling of dMyD88, Tube, Pelle, and DIF (dorsalrelated immu-
nity factor) the NF-kB homolog. Imd an intracellular signalling protein located 
close to the transmembrane PGRP-LE and PGRP-LC proteins, activates Relish 
protein to trigger autophagy and phagocytosis through ImD regulated genes by 
rendering cellular immunity against gram negative bacteria [41]. Toll activates the 
nuclear factor DIF and it promotes humoral immunity in the fat body by produc-
ing varieties of anti-microbial peptides AMPs like attacin, cecropin, drosomycin, 
defensin, metchnikowin, diptericin and drosocin [42].
The fungal pathogen was found to be recognized by GNBP3 along with PGRPSA 
and GNBP1 it activates the drosophila toll receptors [43]. The Drosophila toll-5 (Tehao) 
and toll-9 plays major role during fungal infection by inducing Drosomycin gene [44].
During the preliminary stage of viral infection Drosophila toll receptor homolog 
of human TLR, Imd (TNF-alpha), Domeless (Jak–STAT), and RNAi plays a major 
role against viral infection these are components of innate immune system [45]. 
Similar to humans the viral glycoproteins are recognized by toll receptors like toll-4, 
while toll-7 dependent autophagy observed during viral infection in flies [42, 46]. 
Jak–STAT and Imd together mediates effective immunity against viral attack in flies 
[47]. The domeless-hop-stat2 pathway stimulated by upd1/2/3 activates Jak–STAT 
regulated genes responsible for controlling viral load; it is homologous to mam-
malian Jak–STAT pathway [48]. The Drosophila P53 and dP38 mediates apoptosis in 
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flies upon stress response generated due to DNA damage, P53 mediated apoptotic 
genes are regulated by Jak–STAT-MAPK [49]. The dP38 stimulation in flies trig-
gers Unpraired gene (upd protein) a mammalian IL-6 homolog further activates 
Jak–STAT-Turandots pathway which increases tolerance towards the viral invasion 
[50]. The intrinsic to cell the Dicer2 a viral sensor protein mediates silencing through 
RNA-induced silencing complex (RISC) dependent RNAi production which inhibits 
viral components transcription and vago gene activation finally controls viral growth 
[51, 52]. The anti-viral RNAi are transported from one cell to another through 
canonical nano-tubes structures [53]. dERK pathway regulates viral infection of 
flies gut epithelial infection during orally challenge of arbovirus, Sindbis virus and 
vesicular stomatitis virus [54]. Despite of dynamic immune response against the 
viral infection viruses like Nora virus, Sigma virus (DmelSV), Drosophila C virus 
(DCV), and Drosophila X virus (DXV) can cause fatality in flies [55].
5. Markers of infectious diseases
In the recent decades extensive research has been conducted to understand the 
regulation of immune system in Drosophila melanogaster. Using techniques like 
genome wide screens, Drosophila S2 cell line in-vitro models and tissue specific loss 
of function mutation in transgenic GAL4/UAS fly allows studying selective path-
ways of immune response [56]. Up-regulation of antimicrobial peptides (AMP) in 
flies during bacterial and fungal infection was frequently observed, these six AMP 
genes expression level could be analyzed in flies [42, 57]. ROS level in flies trigger 
several pathways responsible for tolerance (cell survival) and apoptosis (cell death) 
could be assayed in virally infected flies [49, 50]. Rescue of diseased transgenic flies 
upon feeding of desired drug could reveal drug efficacy [56]. Survival of flies would 
further reveal the effect of drugs during an ongoing pathogenesis [58].
6. Behavioral and physiological characterization of infected flies
6.1 Negative geotaxis assay
Negative geotaxis assay serves the purpose to manifest ongoing pathogenesis 
inside the live model. It was demonstrated previously that infected flies display 
significantly lesser motility than healthy flies when exposed under bright light. 
It could be considered as an important parameter to explain drug efficacy while 
screening anti-microbial drugs in flies [59].
6.2 Circadian rhythm
Circadian rhythm in flies was studied, the genes timeless or period controls the 
circadian rhythm of activity-sleep cycle during day-night respectively. It has been 
observed that infected flies exhibit interrupted circadian control of locomotion 
thus flies with this deficit shows restlessness at the same time gets lesser sleep than 
normal flies. The behavioral changes could also be studied in infected flies beside 
the control/uninfected flies [60].
6.3 Wasting
Wasting is commonly seen physiological changes associated with prolonged 
diseased condition in humans. Wasting is a common symptom in HIV/AIDS, 
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tuberculosis and cholera patients. Similarly rapid loss in weight could be seen in 
infected flies prior to its death [61, 62].
7. Factors contributing to suitable infection model
It was previously reported that in order to replicate the outcome of future stud-
ies it is important to optimize the lethal dosage selection and the route of inoculum 
[63]. It is suggested that the selection of microbial strain and gender of flies are two 
important factors which could potentially impact the findings of future research.
7.1 Route of inoculum
There are two prime techniques for inducing infection in flies, primarily by 
feeding the flies with the microbes secondly by pricking micro needles dipped in 
bacterial liquid (inoculum) into fly’s abdomen or thorax [62, 63]. Flies could be 
pricked in the abdomen with micro-needle dipped in the microbial solution, known 
amount can be useful in pharmacodynamic as well as pharmacokinetic studies [64].
7.2 Flies gender selection
Selecting gender should be considered strictly, few studies do not prefer to 
report the reason behind choosing the gender male/female type. In a study with 
Vibrio cholera infection narrated that female flies survived approximately 24 h 
longer than male flies [65].
8. In-vivo models for epidemic and pandemic diseases
The existing models using live bacterial infusion, feeding fungal strains and 
transgenic flies expressing viral proteins. Under immuno-suppressed condition 
would serve multiple purposes like studying host pathogen interaction and con-
ducting preclinical trials [62, 66].
8.1 HIV models
Since human viruses do not usually invade insects the use of Drosophila mela-
nogaster as a model organism is critical and currently in less usage [67]. In order to 
establish an HIV model for drug screening in Drosophila melanogaster it is important 
to understand the structural components of human immunodeficiency virus 
(HIV). The envelope components are comprised of Gp120 and Gp41 encoded by 
env sequence, pol-Gag RNA material encodes for Matrix, capcid, nuclear capsid, p6, 
Protease, reverse transcriptase, and Integrase), Vif, Vpr, Nef, vpu, tat, and Rev [68]. 
Transfection of Tat (transcription activator), Vpu (helps virion budding), Nef 
(regulator of structural gene expression) and Rev. (Nuclear export protein) in flies 
(in-vitro/in-vivo) were previously shown, these transfection models could be use-
ful due to the fact that there is no marketed drug to target these viral proteins [69].
The incapacity of Drosophila S2 cells is only associated with the expression of 
HIV-1 envelope proteins. It is possible to express gycosylated and cleaved Gp120 in 
S2 cells but fusion with CD4+ receptors of T-helper cells could not be achieved in 
the model expression system [70]. In another study the expression of Gp120 in dro-
sophila was carried out in S2 cell line, the antigen Gp-120 did not exhibited T-helper 
cell mediated humoral immune system activation and IgG antibody generation, 
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when introduced in mice [71]. Due to this usual challenge in a different study they 
expressed HIV-1 virus like proteins in Drosophila S2 cells [72].
The nef transgenic flies exhibited JNK mediated apoptosis further nef inhibits 
NF-kB necessary for Relish gene activation similarly decreased immune response is 
common in AIDS patients [73]. In a study transfected viral protein Vpu was shown 
to cause immune suppression in fat body of flies via toll dependent pathway, in 
wings the Vpu expression caused apoptosis and hindered wing development, in 
mammals Vpu is known for causing T-cell lymphocyte death in infected patients 
[74, 75]. Active microbial invasion in nef flies should be further confirmed before 
targeting with potent anti-nef drug candidate. The Rev transfected S2 cells revealed 
that expression of Rev. protein directed the translocation of viral mRNA sequence 
into the cytoplasm, blocked by leptomycin B a secondary metabolite of Streptomyces 
species [76]. Leptomycin B remained unapproved in clinical trials due to high toxic-
ity in cancer patients [77]. The ART drugs like zidovudine, lamivudine, stavudine, 
didanosine and abacavir were introduced in D. melanogaster to study genotoxicity 
profile [78, 79]. In Drosophila oocytes Tat a nuclear shuttling protein, displayed 
interaction with tubulin causing dorso-ventral axis mislocalization resulting in 
delayed microtubule polymerization, similarly tubulin dysfunction causes neuro-
logical symptoms observed in HIV+ individuals [80]. The transfected viral proteins 
in live Drosophila could be used to target drug in a thoughtfully designed model.
Cryptococcosis, Candidiasis and Aspergillosis are common types of fungal 
infections observed as clinical challenge in HIV-positive patients [81]. Under immu-
nosuppressed condition the invasion of fungi in flies causes fatality. In Drosophila 
fungal infection could be difficult to achieve as the innate immune system mediates 
anti-fungal peptide production by haemocyte causing decrease of fungal load and 
increases fly survival rate [82]. Hence Toll mutant flies were generated and used to 
induce fungal infection.
Fluconazole and voriconazole showed anti-fungal activity against Candida 
albicans and Aspergilus fumigatus respectively in flies [64, 83]. Among Cryptococcus 
species only Cryptococcus neoformans is capable of killing flies with mutated toll 
receptors in drosophila, susceptible to infection acquired from Cryptococcus species 
like Cryptococcus kuetzingii or Cryptococcus laurentii [83]. Although, the toll mutant 
flies do not demonstrate an HIV model, it is used to induce fungal infection which 
can serve as a model for fungal infection in Drosophila for drug screening purpose.
In order to study HPV and EBV there are two model systems to study the effect 
in flies. In the study with HPV co-expression of viral oncoprotein E6 and human 
UBE3A did not resulted in tumorigenesis requires Ras or Notch pathway in flies, 
E6-UBE3A requires insulin receptors for cancer to develop [84]. Upon introducing 
the BZLF1 gene of EBV led to interaction with shaven gene in flies a homolog of 
pax gene family of humans responsible for B-cell development [85]. Expression of 
BRLF1 and BZLF1 genes using GMR-R model in Drosophila showed BRLF1 caused 
overproliferation of cells in flies whereas, BZLF1 resulted in interaction with several 
tumor suppressor genes and both viral genes showed interactions with core tumor 
suppressor genes like reaper, p53, Rab5, and Tor [86]. EVB DNA injection in flies 
caused Imd mediated pathway to increase diptericin production at the same time 
hemocyte proliferation and remarkable increase in numbers of hemocyte cells [87]. 
Human cytomegalovirus derived immediate early gene transfection in flies resulted 
in embryonic lethality similar to humans [88].
8.2 Influenza infection models
Influenza virus like most other viruses fails to infect the Drosophila melanogaster. 
To construct a suitable model for drug screening was also an important aspect due 
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to high mortality rate caused by flu virus. The influenza virus coat protein consists 
of hemagglutinin (HA) and neuraminidase (NA). Matrix protein 2 (M2) plays 
a vital role in maintaining the pH level through proton transport enabling viral 
uncoating. Expression of M2 protein in flies is achieved through insertion of M2 
cDNA sequence in upstream activation sequence (UAS) of pCaSpeR3 p-element 
insertion vector gave rise to UAS-M2 flies. The crossover between UAS-M2 and 
C135-Gal4 flies resulted in death at the pupal stage. Therefore the larvae were 
exposed and not the adult flies to anti-influenza drug amantidine which is a M2 
antagonist. Amantadine and several other drugs of its class are not capable of acting 
against the flu virus due to varying viral strain types. Moving further the flu-fly 
model of UAS-M2 could be used to study potential anti-influenza drug [56].
8.3 Pneumococcal pneumonia models
There are several pneumococcal pneumonia infection model studied in drosoph-
ila using Streptococcus pneumoniae, Staphylococcus aureus, Pseudomonas aeruginosa and 
Klebsiella pneumonia. The biofilm formation is widely observed during Streptococcus 
pneumoniae infection in humans [89]. The nasopharyngeal tract is colonized pri-
marily by these gram positive rods bacteria prior to infecting the lower respiratory 
tract. Similarly the Pseudomonas aeruginosa exhibit the biofilm formation during 
nasocomial infection in humans, a common culprit causing community acquired 
pneumonia hospitalized in patients [57, 90]. Pseudomonas aeruginosa was shown to 
infect Drosophila melanogaster causing its gut epithelium inflammation [57].
Staphylococcus aureus causes osteomyelitis, endocarditis, septicaemia and 
pneumoniae in humans, it can be selected for mimicking pneumoniae infection in 
Drosophila [91]. Staphylococcus aureus caused rapid death of flies within 48 h due to 
inoculation of high lethal dosage, extended survival seen upon exposure to antibi-
otic (tetracycline) [92]. The teichoic acid of peptidoglycan layer in Staphylococcus 
aureus was found to suppress the toll receptors of flies similar to Streptococcus 
pneumoniae toxins autolysin and pneumolysin interacts with toll receptors of 
macrophages in human [93–95]. Klebsiella pneumonia the gram positive bacteria are 
capable of killing drosophila at higher dose [96]. Streptococcus pneumoniae causes 
the maximum deaths in human causing pneumoniae which could be used as a suit-
able model for antibiotic screening in Drosophila melanogaster.
8.4 Tuberculosis models
There are at present two bacterial models for studying mycobacterium infection in 
flies, induced by Mycobacterium marinum and Mycobacterium abscessus. Mycobacterium 
marinum is a non spore forming, non motile, gram positive acid-fast bacillus, which is 
genetically 99.3% similar to Mycobacterium tuberculosis [97, 98]. Vacuole acidification 
is inhibited by M. marinum in drosophila phagocytic cells has been previously identi-
fied to be similar with tuberculosis pathogenesis in humans [99, 100]. Tigecycline plus 
linezolid was shown to have extended fly survival during the Mycobacterium absces-
sus infection. Rifampicin a very potential wide range antibiotics effective to inhibit 
multi drug resistance tuberculosis (MDRTb), it showed antimycobacterial efficacy in 
Drosophila infected with Mycobacterium marinum [101]. Any potential drug candidate 
capable of anti-mycobacterial activity can be studied in these models.
8.5 Cholera models
The bacteria Vibrio cholerae is a gram-negative and motile bacterium causes 
diarrheal disease in human. The pathogenesis of Vibrio cholera infection in humans 
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was previously reported to be symbolized as comparable disease progression in 
Drosophila melanogaster. Ingestion of cholera bacterium results in lethal infection 
induced by the toxins in the intestinal cells of the flies. The toxins ingestion could 
not cause equivalent lethal effect on flies was explained previously. The V. cholera 
infection results in inhibition of adenylyl cyclase, Gsα, or the Gardos K+ channel 
causing death due to oral ingestion in flies. Clotrimazole a Potassium Calcium-
Activated Channel Subfamily N Member 4 (KCNN4) inhibitor exposure increased 
flies susceptibility to V. cholera infection [61]. Quorum sensing is the ability to 
detect and to respond to a specific density of cell population through gene regula-
tion [102]. Drosophila melanogaster initiates quorum sensing during vibrio cholera 
infection by suppressing succinate (substrate of KEBS cycle) uptake in flies intes-
tine, limiting the wasting process [62]. Quorum sensing enables the bacterium to 
remain sessile in the flies gut and Vibrio polysaccharide (VPS) gene expression was 
shown to have increased during V. cholera infection of flies [103].
9. Importance of in-vitro model infection in Drosophila
The Drosophila S2 cells were first discovered by I. Schneider in 1972 [104]. 
S2 cells are derived from primary cell culture of late phase embryo of Drosophila 
melanogaster. S2 cells are macrophage like cells potentially grows in serum free 
medium as non-adherent suspension. S2 cells can express variety of heterologous 
proteins, upto 12 proteins could be co-expressed at a time in highly controlled 
manner, doubling at a rate equivalent to any cell lines derived from human cancer-
ous cell line [105]. These cells do not form coherent clusters with no noisy gene 
expression profiles by maintaining uniformity during expression and chromo-
somal aneuploidy gets compensated during expression self adjusted to one gene 
copy number per cell unlike cancerous lineage [106]. These viable and potent 
cellular characteristics of S2 cell allows to be chosen for vaccine development, large 
scale enzyme as well as hormones production similar to Chinese hamster ovary 
CHO cell lines [104, 107]. The post translational glycosylation process is often not 
achievable in S2 cells making it disadvantageous [105]. The viral infections models 
are slow in inducing fatality in immuno-suppressed mutant flies, 50% death occurs 
after around 18–30 days post infection in live model [44, 108]. Therefore, S2 cell 
line model could requite certain challenges usually observed during in-vivo infec-
tion models.
10. In-vitro model of epidemic and pandemic infectious disease
Using drosophila S2 cell model a study showed that intercellular Mycobacterium 
smegmatis growth inside the host phagosomes is restricted by Rab7, CG8743, and 
the ESCRT factors [109]. Cryptococcus neoformans a fungi responsible for menin-
goencephalitis infection, S2 cells infected by this fungus up-regulates autophagy 
initiating proteins like Atg2a, Atg5 and Atg9a beside lysosomal markers like 
LAMP-1 and cathepsin D [110]. The hepatitis B virus surface antigen (HBsAg) 
coded by S gene was transfected in S2 cell line gave rise to no variation in expressed 
protein suggesting S2 cells useful for expression system [111]. The Plasmodium 
falciparum reticulocyte-binding protein homolog 5 (PfRH5) was expressed in S2 
cells of Drosophila to produce non-glycosylated variants capable of binding to its 
receptor in rabbits resulted in IgG production against PfRH5 protein [112]. Highly 
potential vaccine VAR2CSA against malaria was successfully produced in S2 cells of 
Drosophila melanogaster [113].
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11.  Viral meningitis, encephalitis and hemorrhagic fever S2 cell line 
model
Herpes simplex virus was studied in Drosophila S2 cells where transfection of 
two viral proteins PILRα and gB responsible for binding to mammalian cells were 
expressed found to be poorly glycosylated [114]. The RNAi pathway was indulged 
by host cells to inhibit the Dengue virus (Flavivirus family) infection, by knocking 
down Argonaute (Ago1/2) and Dicer (Dcr1/2) showed sustained viral infection, 
currently clinical trial is underway NCT00936429 [115, 116]. Japanese encephalitis 
virus envelope glycoprotein E transfected in Drosophila S2 cells resulted in stable 
protein expression, this glycoprotein exposure in mice led antibody production 
against it [117]. Infection of Sindbis virus in live flies led activation of Notch, Jak–
STAT and ImD pathway to intervene viral invasion [54]. Notch pathway mediated 
assimilation of ankyrin, plap, syx13, unc-13, csp, rab1 and rab8 during Sindbis virus 
infection in S2 cells [115]. The human antibody MR191 specific against Marburg 
virus was fused with recombinant RAVV GP ectodomain produced in S2 cell line 
[118]. The Zika virus structural envelope (E) protein were efficiently produced and 
secreted from transfected Drosophila S2 cell line model [119]. Flies produces RNAi 
against west Nile virus infection as a result of innate immune response similarly it 
was seen in S2 cell line, S2 cell lines were used for WNV infection, currently vaccine 
development NCT01477580 and NCT00707642 is underway [116, 120]. In a study 
mice were injected with glycoprotein GP of Ebola virus expressed in Drosophila S2 
cell line found to produce antibodies against the infused antigen [121] (Table 1).
Epidemic/
Pandemic Disease
Microbes Vaccine/Drugs screened or 
derived out of fly model (in-vitro/
in-vivo)
References
HIV/AIDS Human Immuno virus Leptomycin B (In-Vitro) 
Unapproved under clinical trials




Flu Influenza A Amantidine [56]






Rifampicin, Tigecycline + Linezolid [100, 101]
SARS SARS Corona virus —
MERS MERS corona virus —
Measles Rubeola virus —
Typhoid Salmonella typhi —
Hepatitis Hepatitis A and B HBsAg expressed in S2 cell line [111]
Small pox Variola virus —
Malaria Plasmodium 
falciparum
VAR2CSA/PfRH5 viral protein 
expressed in S2 cell line
[112, 113]
Zika Fever Zika virus Structural envelope (E) protein 
expressed in S2 cells
[119]
Dengue Fever Dengue Virus DEN1-80E expressed in S2 cells [115, 116]
Encephalitis Japanese encephalitis 
virus
JEV E protein expression in S2 cell 
line
[117]
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12. Disadvantages of Drosophila model for drug screening
Drosophila melanogaster being ectothermic organism unlike humans are endother-
mic homeotherms maintains physiological temperature constantly at 37°C, making 
it difficult to infect flies with bacteria like Mycobacterium tuberculosis grows strictly 
at 37°C [36, 122]. Several pathogenic viruses capable of infecting humans cannot 
naturally infect Drosophila melanogaster [55, 67]. The fungal dose response in flies is 
difficult to measure in oral infection model therefore this model is limited to study 
only the anti-fungal drug efficacy [64]. The presence of symbiotic microbes like 
Wolbachia a gram negative bacteria associate mostly with drosophila gut, improves 
the fly immunity against viral infection [123]. Superinfection like viral pneumonia 
cannot be studied at present to undertake preclinical trial using fly as a model.
13. Future perspective
Irrespective of multiple disadvantages flies could be used for studying drug 
efficacy. Multi-drug resistance tuberculosis infection could be studied in flies. 
The ART medication impairs human heart by causing prolonged QT, prolonged 
arrhythmic condition leads to myocardial infraction, Drosophila could be a suit-
able model to study the effect of anti retroviral therapy on fly heart [124–126]. 
Shockingly infection induced in flies by vesicular stomatitis virus in toll-7 depleted 
flies where 50% flies displayed death after 18 days, suggesting HIV infection could 
also kill toll7 mutant flies, as toll mutant flies displayed fungal invasion, this yet to 
be confirmed [44]. Alternative to this only viral DNA had been shown in a recent 
study to evoke immune activation in Drosophila by injecting it in thoracic region 
[87]. Kaposi sarcoma associated Herpesvirus (KSHV) needs a model which is yet 
to be studied in flies, however the KSHV viral gene latent nuclear antigen (LANA) 
interacts with RING3 of human which is homologous to drosophila female sterile 
homeotic (fsh) has already been identified [127]. Drosophila wound healing an 
important concern while inducing bacterial infection currently it is well understood 
and was found regulated by EGFR/ERK pathway essential for tissue repair [128]. 
The RNAi screens against Dengue or Influenza virus infection in cell culture could 
not identify Jak–STAT, ImD and toll dependent gene activation suggesting pos-
sible alternative pathway associated in infection modulation and no stimulation of 
inflammatory cytokine activation [40]. The food borne Salmonella typhimurium 




Microbes Vaccine/Drugs screened or 
derived out of fly model (in-vitro/
in-vivo)
References
Haemorrhagic fever Ebola virus glycoprotein GP expressed in S2 
cell line
[121]
Haemorrhagic fever Marburg Virus MR191 expressed in S2 cell line [118]
Plague Yersinia pestis —
Yellow fever Yellow fever virus —
West Nile Fever West Nile Virus WN-80E expressed in S2 cell line [116, 120]
Table 1. 
List of Drugs/vaccines screened or developed against Infectious diseases in Drosophila melanogaster as a model 
organism.
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14. Conclusions
Currently the existing models of infection in drosophila are capable of causing infec-
tion using viruses, bacteria (gram negative and gram positive) and fungi. These models 
are of great use since the efficacy of a drug capable of modifying diseased condition 
could be studied in detail in live Drosophila or in-vitro S2 cell. In this detailed review 
on epidemiology of infectious disease, it could be predicted that infection alone is a 
threat to overall population imposing death to more than 5 million individuals. Diseases 
like influenza, HIV, pneumonia, tuberculosis and cholera could be studied in flies. 
Currently there are 20 diseases which caused epidemic worldwide [2], 13 of the patho-
gens were studied in Drosophila melanogaster and diseases caused by yellow fever virus, 
Nipah virus, MERS, Hepatitis C virus, Salmonella typhi, Crimean congo hemorrhagic 
fever virus, chikungunya virus, monkeypox virus, Nipah virus and shigellosis bacteria 
are yet to be studied in-vitro/in-vivo. These diseases are of pandemic and epidemic cri-
teria it causes huge number of deaths globally. Controlling the epidemic and pandemic 
diseases should be the main focus of the healthcare sector in the next decade.
Acknowledgements
I would like to thank Professor Sarat Chandra Yenisetti, Nagaland University, 
India for the effort and advices given for this article. I would like to thank Professor 
David S. Schneider of Stanford University, USA for clearing doubts regarding tuber-
culosis and typhoid infection in flies.
Conflict of interest
The author has no conflict of interest.
Notes/Thanks/Other declarations
I would like to thank the IntechOpen Journal for giving 100% waiver to publish 
this review article. I would like to thank all the researchers for providing their 
complete articles which are unavailable online.
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
14
Animal Models in Medicine and Biology
References
[1] Green MS, Swartz T, Mayshar E, 
Lev B, Leventhal A, Slater PE, et al. 
When is an epidemic an epidemic? 
Israel Medical Association Journal. 
2002;4(1):3-6
[2] World Health Organization. 
Managing epidemics: Key facts about 
major deadly diseases. 2018. ISBN 
978-92-4-156553-0
[3] Hays JN. Epidemics and Pandemics: 
Their Impacts on Human History. ABC-
CLIO. 2005. ISBN 978-1-85109-658-9
[4] World Health Organization. 
What is a pandemic? Emergencies 




[5] Centers for Disease Control and 
Prevention. Vaccines and Preventable 
Diseases. List of Vaccines Used in United 
States. April 13, 2018. [Accessed: 15 
August 2019]
[6] Principles of Epidemiology in 
Public Health Practice, 3rd ed. An 
Introduction to Applied Epidemiology 
and Biostatistics. Centers for Disease 
Control and Prevention. [Retrieved 19 
August 2019]
[7] Unicef. Robin Nandy. Immunization 
under fire. 25 April 2016. [Accessed: 14 
August 2019]
[8] Oppenheim B, Gallivan M, 
Madhav NK, et al. Assessing global 
preparedness for the next pandemic: 
development and application of an 
Epidemic Preparedness Index. BMJ 
Global Health. 2019;4:e001157. DOI: 
10.1136/bmjgh-2018-001157
[9] Boutayeb A. The burden of 
communicable and non-communicable 
diseases in developing countries. 
Transactions of the Royal Society of 
Tropical Medicine and Hygiene. 2010. 
DOI: 10.1007/978-0-387-78665-0_32
[10] Review of Antibacterial Medicines 
for the WHO Model List of Essential 
Medicines 2017 Update. [Accessed: 14 
August 2019]
[11] WHO. The top 10 causes of death. 
Factsheet. 2016. Available at: https://
www.who.int/news-room/fact-sheets/
detail/the-top-10-causes-of-death 
[Accessed: 30 June 2019]
[12] WHO. Influenza (seasonal) fact 
sheet. 2016. Available at: http://www.
who.int/mediacentre/factsheets/fs211/
en/ [Accessed: 01 July 2019]
[13] Mokdad AH, GBD 2015 LRI 
Collaborators. Estimates of the global, 
regional, and national morbidity, 
mortality, and aetiologies of lower 
respiratory tract infections in 195 
countries: A systematic analysis for 
the Global Burden of Disease Study 
2015. Lancet Infectious Diseases. 
2017;17(11):1133-1161
[14] Cunha CB, Opal SM. Middle East 
respiratory syndrome (MERS): A new 
zoonotic viral pneumonia. Virulence. 
2014;5(6):650-654
[15] Ziegler T, Mamahit A, Cox NJ. 65 
years of influenza surveillance by a 
World Health Organization-coordinated 
global network. Influenza Other 
Respiratory Viruses. 2018;12:558-565. 
DOI: 10.1111/irv.12570
[16] Harish Nair W, Brooks A, Katz M, 
Roca A. Global burden of respiratory 
infections due to seasonal infl uenza 
in young children: A systematic 
review and meta-analysis. Lancet. 
2011;378:1917-1930. DOI: 10.1016/
S0140-6736(11)61051-9
[17] Al Johani Sameera, Akhter 
Javed. 2017. Pneumonia of Viral 
15
Drosophila melanogaster: A Robust Tool to Study Candidate Drug against Epidemic…
DOI: http://dx.doi.org/10.5772/intechopen.90073
Etiologies, Contemporary Topics 
of Pneumonia, Zissis C. Chroneos, 
IntechOpen. DOI:10.5772/




[18] Behrens G, Stoll M. Chapter 
4: Pathogenesis and immunology. 
In: Influenza Report. 2006. ISBN: 
3-924774-51-X
[19] WHO. Factsheet. Tuberculosis. 
2018. Available at: https://www.who.int/
newsroom/facsheets/detail/tuberculosis 
[Accessed: 01 July 2019]
[20] Raviglione M, Sulis G. Tuberculosis 
2015: Burden, challenges and strategy 
for control and elimination. Infectious 
Disease Reports. 2016;8(2):6570
[21] Progress report on HIV, viral 
hepatitis and sexually transmitted 
infections 2019. In: Accountability for 
the Global Health Sector Strategies, 
2016-2021. Geneva: World Health 
Organization; 2019 (WHO/CDS/
HIV/19.7). Licence: CC BY-NC-SA 3.0 
IGO
[22] Sen S. Indian cholera: A myth. 
Indian Journal of History of Science. 
2012;47(3):345-374
[23] 150 years of cholera epidemiology. 
Lancet. 2005;366(9490):957
[24] Harris JB, La Rocque RC, Qadri F, 
Ryan ET, Calderwood SB. Cholera. 
Lancet. 2012;379:2466-2476
[25] WHO. Cholera. Fact sheet 
[Internet]. Available at: https://www.
who.int/newsroom/factsheets/detail/
cholera [Accessed: 30 June 2019]
[26] Jefferies M, Rauff B, Rashid H, 
Lam T, Rafiq S. Update on global 
epidemiology of viral hepatitis and 
preventive strategies. World Journal of 
Clinical Cases. 2018;6(13):589-599
[27] World Health Organization. Global 
Hepatitis Report 2017. World Health 
Organization. 2017. Available at: https://
apps.who.int/iris/handle/10665/255016. 
License: CC BY-NC-SA 3.0 IGO
[28] Ashurst JV, Truong J, Woodbury B. 
Salmonella Typhi. 2019. Bookshelf ID: 
NBK519002, PMID: 30085544
[29] WHO. Typhoid. Factsheet. 11 
September 2018. Available at: https://
www.who.int/immunization/diseases/
typhoid/en/ [Accessed: 05 July 2019]
[30] WHO. Malaria. Factsheet. 27 March 
2019. Available at: https://www.who.int/
news-room/fact-sheets/detail/malaria 
[Accessed: 05 July 2019]
[31] CDC. Meningitis Home. August 6, 
2019. Available at: https://www.cdc.
gov/meningitis/viral.html [Accessed: 18 
August 2019]
[32] WHO. Health topics encephalitis. 
Viral Available at: https://www.who.int/
topics/encephalitis_viral/en/
[33] New York State Department of 
Health. Arboviral (Arthropod-borne 




[34] Fernando Cobo Viruses 
Causing Hemorrhagic Fever. Safety 
Laboratory Procedures. The Open 
Virology Journal. 2016;10:1-9. DOI: 
10.2174/1874357901610010001
[35] Panayidou S, Ioannidou E, 
Apidianakis Y. Human pathogenic 
bacteria, fungi, and viruses in 
Drosophila. Virulence. 2014;5(2):253-
269. DOI: 10.4161/viru.27524
[36] Tzelepis I, Kapsetaki S-E, 
Panayidou S, Apidianakis Y. Drosophila 
melanogaster: A first step and a 
stepping-stone to anti-infectives. 
Current Opinion in Pharmacology. 




[37] Dionne MS, Schneider DS. Models 
of infectious diseases in the fruit fly 
Drosophila melanogaster. Disease 
Models & Mechanisms. 2008;1:43-49. 
DOI: 10.1242/dmm.000307
[38] Bergman P, Seyedoleslami 
Esfahani S, Engstrom Y. Drosophila as 
a model for human diseases—Focus on 
innate immunity in barrier epithelia. 
Current Topics in Developmental 
Biology. 2017;121:29-81. DOI: 10.1016/
bs.ctdb.2016.07.002
[39] De Gregorio E, Spellman PT, 
Rubin GM, Lemaitr B. Genome-wide 
analysis of the Drosophila immune 
response by using oligonucleotide 
microarrays. Proceedings of the National 
Academy of Sciences of the United 
States of America. 2001;98(22):12590-
12595. DOI: 10.1073/pnas.221458698
[40] Sabin LR, Hanna SL, Cherry S.  
Innate antiviral immunity in 
Drosophila. Current Opinion in 
Immunology. 2010;22:4-9
[41] Martin M, Hiroyasu A, 
Guzman RM, Roberts SA, Goodman  
AG. Analysis of Drosophila STING 
reveals an evolutionarily conserved 
antimicrobial function. Cell Reports. 
23:3537-3550. DOI: 10.1016/j.
celrep.2018.05.029
[42] Rutschmann S, Jung AC, 
Hetru C, Reichhart JM, Hoffmann JA, 
Ferrandon D. The Rel protein DIF 
mediates the antifungal but not the 
antibacterial host defense in Drosophila. 
Immunity. 2000;12(5):569-580. DOI: 
10.1016/S1074-7613(00)80208-3
[43] Gottar M, Gobert V, Matskevich AA, 
Reichhart J-M, Wang C, Butt TM, et al. 
Dual detection of fungal infections 
in Drosophila through recognition 
of microbial structures and 
sensing of virulence factors. Cell. 
2006;127(7):1425-1437. DOI: 10.1016/j.
cell.2006.10.046
[44] Nakamoto M, Moy RH, Xu J, 
Bambina S, Yasunaga A, Shelly SS, et al. 
Virus recognition by Toll-7 activates 
antiviral autophagy in Drosophila. 
Immunity. 2012;36:658-667. DOI: 
10.1016/j.immuni.2012.03.003
[45] Lopez WA, Page AM, Ericson BL, 
Carlson DJ, Carlson KA. Antiviral 
immunity in the fruit fly, Drosophila 
melanogaster, Drosophila melanogaster. 
In: Perveen FK, editor. Model for Recent 
Advances in Genetics and Therapeutics. 
IntechOpen; 2017. DOI: 10.5772/
intechopen.69293
[46] Akira S, Uematsu S, Takeuchi O.  
Pathogen recognition and innate 
immunity. Cell. 2006;124:783-801
[47] Huang Z, Kingsolver MB, 
Avadhanula V, Hardy RW. An antiviral 
role for antimicrobial peptides during 
the arthropod response to alphavirus 
replication. Pathogenesis and Immunity. 
DOI: 10.1128/JVI.03360-12
[48] Dostert C, Jouanguy E, Irving P, 
Troxler L, Galiana-Arnoux D, Hetru C, 
et al. The Jak-STAT signaling pathway 
is required but not sufficient for the 
antiviral response of drosophila. Nature 
Immunology. 2005;6(9):946. DOI: 
10.1038/ni1237
[49] Liu B, Behura SK, Clem RJ, 
Schneemann A, Becnel J, et al. P53-
mediated rapid induction of apoptosis 
conveys resistance to viral infection 
in Drosophila melanogaster. PLoS 
Pathogens. 2013;9(2):e1003137. DOI: 
10.1371/journal.ppat.1003137
[50] West C, Silverman N. p38b and 
JAK-STAT signaling protect against 
Invertebrate iridescent virus 6 infection 




Drosophila melanogaster: A Robust Tool to Study Candidate Drug against Epidemic…
DOI: http://dx.doi.org/10.5772/intechopen.90073
[51] Poirier EZ, Goic B, Tome-Poderti L, 
Frangeul L, Boussier J, Gausson V, et al. 
Dicer-2-dependent generation of viral 
dna from defective genomes of RNA 
viruses modulates antiviral immunity 
in insects. Cell Host & Microbe. 
2018;23:353-365. DOI: 10.1016/j.
chom.2018.02.001
[52] Takeuchi O, Akira S. RIG-I-like 
antiviral protein in flies. Nature 
Immunology. 2008;9(12):1327
[53] Karlikow M, Goic B, Mongelli V, 
Salles A, Schmitt C, Bonne I, et al. 
Drosophila cells use nanotube-like 
structures to transfer dsRNA and RNAi 
machinery between cells. Scientific 
Reports. 6:27085. DOI: 10.1038/srep27085
[54] Xu J, Hopkins K, Sabin L, 
Yasunaga A, Subramanian H, 
Lamborn I, et al. ERK signaling couples 
nutrient status to antiviral defense in the 
insect gut. PNAS. 2013;110(37):15025-
15030. DOI: 10.1073/pnas.1303193110
[55] Xu J, Cherry S. Viruses and antiviral 
immunity in Drosophila. Developmental 
and Comparative Immunology. 
2014;42(1). DOI: 10.1016/j.
dci.2013.05.002
[56] Adamson AL, Chohan K, Swenson J, 
La Jeunesse D. A Drosophila model for 
genetic analysis of influenza viral/host 
interactions. Genetics. 2011;189:495-
506. DOI: 10.1534/genetics.111.132290
[57] Mulcahy H, Sibley CD, Surette MG, 
Lewenza S. Drosophila melanogaster 
as an animal model for the study 
of Pseudomonas aeruginosa biofilm 
infections in vivo. PLoS Pathogens. 
2011;7:e1002299. DOI: 10.1371/journal.
ppat.1002299
[58] Blow NS, Salomon RN, Garrity K, 
Reveillaud I, Kopin A, Rob Jackson F, 
et al. Vibrio cholerae infection of 
Drosophila melanogaster mimics the 
human disease cholera. PLoS Pathogens. 
2005;1(1):e8
[59] Allen JA, Chambers M, 
Gupta AS, Schneider D. Infection-
related declines in chill coma 
recovery and negative geotaxis in 
Drosophila melanogaster. PLoS One. 
2012;7(9):e41907. DOI: 10.1371/
journal.pone.0041907
[60] Shirasu-Hiza MM, Dionne MS, 
Pham LN, Ayres JS, Schneider DS. 
Interactions between circadian rhythm 
and immunity in Drosophila 
melanogaster. Current Biology. 
2007;17(10):R354
[61] Dionne MS, Pham LN, Shirasu- 
Hiza M, Schneider DS. Akt and foxo 
dysregulation contribute to infection-
induced wasting in Drosophila. Current 
Biology. 2006;16(20):1977-1985. DOI: 
10.1016/j.cub.2006.08.052
[62] Kamareddine L, ACN W, 
Vanhove A, Hang S, Purdy A, 
Kierek-Pearson K, et al. Activation 
of Vibrio cholerae quorum sensing 
promotes survival of an arthropod host. 
Nature Microbiology. 2018;3. DOI: 
10.1038/s41564-017-0065-7
[63] Chambers MC, Jacobson E, 
Khalil S, Lazzaro BP. Thorax injury 
lowers resistance to infection in 
Drosophila melanogaster. Infection and 
Immunity. October 2014;82(10):4380-
4389. DOI: 10.1128/IAI.02415-14
[64] Chamilos G, Lionakis MS, 
Lewis RE, Lopez-Ribot JL, Saville SP, 
Albert ND, et al. Drosophila melanogaster 
as a facile model for large-scale studies 
of virulence mechanisms and antifungal 
drug efficacy in Candida species. 
The Journal of Infectious Diseases. 
2006;193:1014-1022
[65] Berkey CD, Blow N, Watnick PI. 
Genetic analysis of Drosophila 
melanogaster susceptibility to intestinal 
Vibrio cholerae infection. Cellular 
Microbiology. 2009;11(3):461-474. DOI: 
10.1111/j.1462-5822.2008.01267.x
Animal Models in Medicine and Biology
18
[66] Hughes TT, Allen AL, Bardin JE, 
Christian MN, Daimon K, Dozier KD, 
et al. Drosophila as a genetic model for 
studying pathogenic human viruses. 
Virology. 2012;423:1-5. DOI: 10.1016/j.
virol.2011.11.016
[67] Cherry S, Perrimon N. Entry is a 
rate-limiting step for viral infection 
in a Drosophila melanogaster model of 
pathogenesis. Nature Immunology. 
2004;5(1):81-87. DOI: 10.1038/ni1019
[68] Frankel AD, John AT. Young  
HIV-1: Fifteen proteins and an 
RNA. Annual Review of Biochemistry. 
1998;67:1-25
[69] Arts1 EJ, Hazuda DJ. HIV-1 
antiretroviral drug therapy. Cold Spring 
Harbor Perspectives in Medicine. 
2012;2:a007161
[70] Ivey-Hoyle M,  Clark RK, 
Rosenberg M. The N-terminal 31 amino 
acids of human immunodeficiency virus 
type 1 envelope protein gpl20 contain 
a potential gp4l contact site. Journal of 
Virology. 1991:2682-2685
[71] Grundner C, Pancera M, Kang J-M, 
Koch M, Sodroski J, Wyatt R. Factors 
limiting the immunogenicity of HIV-1 
gp120 envelope glycoproteins. Virology. 
2004;330:233-248
[72] Yang L, Song Y, Li X, Huang X, 
Liu J, Ding H, et al. HIV-1 virus-like 
particles produced by stably transfected 
Drosophila S2 cells: A desirable vaccine 
component. Journal of Virology. 
2012;86(14):7662-7676
[73] Lee SB, Park J, Jung JU, Chung JK. 
Nef induces apoptosis by activating 
JNK signalling pathway and inhibits 
NF-kB-dependent immune responses 
in Drosophila. Journal of Cell Science. 
2005;118:1851-1859. DOI: 10.1242/
jcs.02312
[74] Leulier F, Marchal C, Miletich I, 
Limbourg-Bouchon B, Benarous R, 
Lemaitre B. Directed expression of 
the HIV-1 accessory protein Vpu in 
Drosophila fat-body cells inhibits Toll-
dependent immune responses. EMBO 
Reports. 2003;4(10)
[75] Marchal C, Vinatier G, Sanial M, 
Plessis A, Pret A-M, et al. The HIV-1 
Vpu protein induces apoptosis in 
drosophila via activation of JNK 
signaling. PLoS One. 2012;7(3):e34310. 
DOI: 10.1371/journal.pone.0034310
[76] Fasken MB, Saunders R, 
Rosenbergi M, David W, Brighty A. 
Leptomycin B-sensitive homologue 
of human CRM1 promotes nuclear 
export of nuclear export sequence-
containing proteins in Drosophila cells. 
The Journal of Biological Chemistry. 
2000;275(3):1878-1886
[77] Klahn P, Fetz V, Ritter A, Collisi W, 
Hinkelmann B, Arnold T, et al. The 
nuclear export inhibitor aminoratjadone 
is a potent effector in extracellular-
targeted drug conjugates. Chemical 
Science. 2019;10:5197-5210. DOI: 
10.1039/C8SC05542D
[78] Guimaraes NN, Silva CJ, 
de Andrade HHR, Dihl RR, 
Lehmann M, Cunha KS. Comparative 
analysis of genetic toxicity of 
antiretroviral combinations in somatic 
cells of Drosophila melanogaster.  
Food and Chemical Toxicology. 
2013;53:299-309. DOI: 10.1016/j.
fct.2012.12.005
[79] Chen-Chen L, de Jesus Silva 
Carvalho C, de Moraes Filho AV, 
Veras JH, Cardoso CG, Bailao EFLC, 
et al. Toxicity and genotoxicity induced 
by abacavir antiretroviral medication 
alone or in combination with zidovudine 
and/or lamivudine in Drosophila 
melanogaster. Human and Experimental 
Toxicology. 2019;38(4):446-454. DOI: 
10.1177/0960327118818248
[80] Piero A, Battaglia SZ, Macchini A, 
Franca Gigliani A. Drosophila model of 
19
Drosophila melanogaster: A Robust Tool to Study Candidate Drug against Epidemic…
DOI: http://dx.doi.org/10.5772/intechopen.90073
HIV-Tat-related pathogenecity. Journal 
of Cell Science. 2001;114:2787-2794
[81] Marukutira T, Huprikar S, 
Azie N, Quan S-P, Meier-Kriesche H-U, 
Horn DL. Clinical characteristics and 
outcomes in 303 HIV-infected patients 
with invasive fungal infections: Data 
from the Prospective Antifungal 
Therapy Alliance registry, a multicenter, 
observational study. HIV AIDS (Auckl). 
2014;6:39-47
[82] Lionakis MS, Lewis RE, May GS, 
Wiederhold NP, Albert ND, Halder G, 
et al. Toll-deficient Drosophila flies as 
a fast, high-throughput model for the 
study of antifungal drug efficacy against 
invasive Aspergillosis and Aspergillus 
virulence. The Journal of Infectious 
Diseases. 2005;191:1188-1195
[83] Apidianakis Y, Rahme LG, 
Heitman J, Ausubel FM, Calderwood SB, 
Mylonakis E. Challenge of Drosophila 
melanogaster with Cryptococcus 
neoformans and role of the innate 
immune response. Eukaryotic Cell. 
2004;3(2):413-419. DOI: 10.1128/
EC.3.2.413-419.2004
[84] Padash Barmchi M, Gilbert M, 
Thomas M, Banks L, Zhang B, Auld VJ. 
A Drosophila model of HPV E6-induced 
malignancy reveals essential roles for 
Magi and the insulin receptor. PLoS 
Pathogens. 2016;12(8):e1005789. DOI: 
10.1371/journal.ppat.1005789
[85] Adamson AL, Wright N, 
LaJeunesse DR. Modeling early Epstein-
Barr virus infection in Drosophila 
melanogaster: The BZLF1 protein. 
Genetics. 2005;171:1125-1135. DOI: 
10.1534/genetics.105.042572
[86] Adamson A, La Jeunesse D. A study 
of Epstein-Barr virus BRLF1 activity in a 
Drosophila model system. The Scientific 
World Journal. 2012; Article ID 347597, 
9 pages. DOI: 10.1100/2012/347597
[87] Sherri N, Salloum N, Mouawad C, 
Haidar-Ahmad N, Shirinian M, 
 Rahal EA. Epstein-Barr virus DNA 
enhances diptericin expression 
and increases hemocyte numbers 
in Drosophila melanogaster via the 
immune deficiency pathway. Frontiers 
in Microbiology. 2018;9:1268. DOI: 
10.3389/fmicb.2018.01268
[88] Steinberg R, Shemer-Avni Y, 
Adler N, et al. Human cytomegalovirus 
immediate-early-gene expression 
disrupts embryogenesis in transgenic 
Drosophila. Transgenic Research. 
2008;17:105. DOI: 10.1007/
s11248-007-9136-5
[89] Chao Y, Marks LR, Pettigrew EM, 
Hakansson AP. Streptococcus pneumoniae 
biofilm formation and dispersion 
during colonization and disease. 
Frontiers in Cellular and Infection 
Microbiology. 2015. DOI: 10.3389/
fcimb.2014.00194
[90] Bassetti M, Vena A, Croxatto A, 
Righi E, Guery B. How to manage 
Pseudomonas aeruginosa infections. 
Drugs in Context. 2018;7:212527. DOI: 
10.7573/dic.212527
[91] Apidianakis Y, Pitsouli C, 
Perrimon N, Rahme L. Synergy between 
bacterial infection and genetic 
predisposition in intestinal dysplasia. 
Proceedings of the National Academy 
of Sciences of the United States of 
America. 2009;106:20883-20888. DOI: 
10.1073/pnas.0911797106
[92] Needham AJ, Kibart M, Crossley H, 
Ingham PW, Foster SJ. Drosophila 
melanogaster as a model host for 
Staphylococcus aureus infection. 
Microbiology. 2004;150:2347-2355. DOI: 
10.1099/mic.0.27116-0
[93] Ragle BE, Karginov VA, 
Wardenburg JB. Prevention and 
treatment of Staphylococcus aureus 
pneumonia with a - cyclodextrin 
derivative. Antimicrobial Agents and 
Chemotherapy. 2010:298-304. DOI: 
10.1128/AAC.00973-09
Animal Models in Medicine and Biology
20
[94] Kurokawa K, Gong JH, Ryu KH, 
Zheng L, Chae JH, Kim MS, et al. 
Biochemical characterization 
of evasion from peptidoglycan 
recognition by Staphylococcus aureus 
D-alanylated wall teichoic acid in 
insect innate immunity. Developmental 
and Comparative Immunology. 
2011;35:835-839. DOI: 10.1016/j.
dci.2011.03.001
[95] Mook-Kanamori BB, Geldhoff M,  
van der Poll T, van de Beek D. 
Pathogenesis and pathophysiology of 
pneumococcal meningitis. Clinical 
Microbiology Reviews. 2011;24(3):557-
591. DOI: 10.1128/CMR.00008-11
[96] Benghezal M, Fauvarque M-O, 
Tournebize R, Froquet R, Marchetti A, 
Bergeret E, et al. Specific host genes 
required for the killing of Klebsiella 
bacteria by phagocytes. Cellular 
Microbiology. 2006;8(1):139-148. DOI: 
10.1111/j.1462-5822.2005.00607.x
[97] Pham LN, Dionne MS, 
Shirasu-Hiza M, Schneider DS. A 
specific primed immune response in 
Drosophila is dependent on phagocytes. 
PLoS Pathogens. 2007;3(3):e26. DOI: 
10.1371/journal.ppat.0030026
[98] Akram SM, Aboobacker S. 
Mycobacterium Marinum. Treasure 
Island (FL): StatPearls Publishing; 
2019. Available from: https://www.
ncbi.nlm.nih.gov/books/ 
NBK441883/
[99] Sakamoto K. The pathology of 
Mycobacterium tuberculosis infection. 
Veterinary Pathology;49(3):423-439
[100] Dionne MS, Ghori N, 
Schneider DS. Drosophila melanogaster 
is a genetically tractable model host 
for Mycobacterium marinum. Infection 
and Immunity. 2003:3540-3550. DOI: 
10.1128/IAI.71.6.3540-3550.2003
[101] Chun-Taek O, Moon C, Ok KP, Kwon 
S-H, Jang J. Novel drug combination for 
Mycobacterium abscessus disease therapy 
identified in a Drosophila infection 
model. The Journal of Antimicrobial 
Chemotherapy. 2014;69:1599-1607. DOI: 
10.1093/jac/dku024
[102] Whitehead NA, Barnard AML, 
Slater H, Simpson NJL, Salmond GPC. 
Quorum-sensing in Gram-negative 
bacteria. FEMS Microbiology Reviews. 
2001;25:365-404
[103] Purdy AE, Watnick PI. Spatially 
selective colonization of the arthropod 
intestine through activation of Vibrio 
cholera biofilm formation. PNAS. 
2011;108(49):19737-19742
[104] Adriaan de Jongh W, Salgueiro S, 
Dyring C. The use of Drosophila S2 
cells in R&D and bioprocessing. 
Pharmaceutical Bioprocessing. 
2013;1(2):197-213
[105] Moraes AM, Jorge SAC, Astray RM, 
Suazo CAT, Riquelme CEC, Augusto EFP, 
et al. Drosophila melanogaster S2 cells 
for expression of heterologous genes: 
From gene cloning to bioprocess 
development. Biotechnology Advances. 
2012;30:613-628. DOI: 10.1016/j.
biotechadv.2011.10.009
[106] Cherbas L, Willingham A, 
Zhang D, Yang L, Zou Y, Eads BD, et al. 
The transcriptional diversity of 25 
Drosophila cell lines. Genome Research. 
2011;21(2):301-314. DOI: 10.1101/
gr.112961.110
[107] Backovic M, Johansson DX, 
Klupp BG, Mettenleiter TC,  
Persson MAA, Rey FA. Efficient method 
for production of high yields of Fab 
fragments in Drosophila S2 cells. Protein 
Engineering, Design & Selection. 
2010;23(4):169-174. DOI: 10.1093/
protein/gzp08
[108] Liu Y, Gordesky-Gold B, Leney- 
Greene M, Weinbren NL, Tudor M, 
Inflammation-Induced SC. STING-
dependent autophagy restricts Zika 
21
Drosophila melanogaster: A Robust Tool to Study Candidate Drug against Epidemic…
DOI: http://dx.doi.org/10.5772/intechopen.90073
virus infection in the Drosophila brain. 
Cell Host & Microbe. 24:57-68. DOI: 
10.1016/j.chom.2018.05.022
[109] Philips JA, Porto MC, Wang H, 
Rubin EJ, Perrimon N. ESCRT factors 
restrict mycobacterial growth. 3070-
3075. PNAS. 2008;105(8). DOI: 10.1073.
pnas.0707206105
[110] Qin Q-M, Luo J, Lin X, Pei J, Li L, 
et al. Functional analysis of host factors 
that mediate the intracellular lifestyle 
of Cryptococcus neoformans. PLoS 
Pathogens. 2011;7(6):e1002078. DOI: 
10.1371/journal.ppat.1002078
[111] Jorge SAC, Santos AS, Spina A, 
Pereira CA. Expression of the hepatitis 
B virus surface antigen in Drosophila S2 
cells. Cytotechnology. 2008;57:51-59
[112] Hjerrild KA, Jin J, Wright KE, 
Brown RE, Marshall JM, Labbe GM, 
et al. Production of full-length soluble 
Plasmodium falciparum RH5 protein 
vaccine using a Drosophila melanogaster 
Schneider 2 stable cell line system. 
Scientific Reports;6:30357. DOI: 
10.1038/srep30357
[113] de Jongh WA, Resende M d SM, 
Leisted C, Stroaek A, Berisha B, 
Nielsen MA, et al. Development of a 
Drosophila S2 insect-cell based placental 
malaria vaccine production process. 
BMC Proceedings. 2013;7(Suppl 6):P20. 
Available at: http://www.biomedcentral.
com/1753-6561/7/S6/P20
[114] Fan Q , Bohannon KP, 
Longnecker R. Drosophila Schneider 
2 (S2) cells: A novel tool for studying 
HSV-induced membrane fusion. 
Virology. 2013;437(2):100-109. DOI: 
10.1016/j.virol.2013.01.004
[115] Mukherjee S, Hanley KA. RNA 
interference modulates replication of 
dengue virus in Drosophila melanogaster 
cells. BMC Microbiology. 2010;10:127. 
Available at: http://www.biomedcentral.
com/1471-2180/10/127
[116] Medina LO, Albert TO, 
Lieberman MM, Wong TAS, Namekar M, 
Nakano E, et al. A recombinant subunit 
based Zika virus vaccine is efficacious 
in non-human primates. Frontiers 
in Immunology. 2018;9:2464. DOI: 
10.3389/fimmu.2018.02464
[117] Zhang F, Ma W, Zhang L, 
Aasa-Chapman M, Zhang H. Expression 
of particulate-form of Japanese 
encephalitis virus envelope protein in a 
stably transfected Drosophila cell line. 
Virology Journal. 2007;4(17). DOI: 
10.1186/1743-422X-4-17
[118] King LB, Fusco ML, Flyak AI, 
Ilinykh PA, Huang K, Gunn B, et al. 
The Marburgvirus-neutralizing 
human monoclonal antibody MR191 
targets a conserved site to block virus 
receptor binding. Cell Host Microbe. 
2018;23(1):101-109.e4. DOI: 10.1016/j.
chom.2017.12.003
[119] Qu P, Zhang W, Li D, Zhang C, Liu 
Q , Zhang X, et al. Insect cell-produced 
recombinant protein subunit vaccines 
protect against Zika virus infection. 
Antiviral Research. 2018 Jun;154:97-103. 
DOI: 10.1016/j.antiviral.2018.04.010 
Epub 2018 Apr 14
[120] Chotkowski HL, Ciota AT, Jia Y, 
Puig-Basagoiti F, Kramer LD, Shi PY, 
et al. West Nile virus infection of 
Drosophila melanogaster induces a 
protective RNAi response. Virology. 
2008;377(1):197-206. DOI: 10.1016/j.
virol.2008.04.021
[121] Lai C-Y, Strange DP, Wong TAS, 
Lehrer AT, Verma S. Ebola virus 
glycoprotein induces an innate immune 
response in vivo via TLR4. Frontiers 
in Microbiology. 2017. DOI: 10.3389/
fmicb.2017.01571
[122] Giraldo D, Adden A, Kuhlemann I, 
Gras H, Bart RH. Geurten correcting 
locomotion dependent observation biases 
in thermal preference of Drosophila. 
Scientific Reports. 2019;9:3974
Animal Models in Medicine and Biology
22
[123] Teixeira L, Ferreira A, 
Ashburner M. The bacterial symbiont 
Wolbachia induces resistance to 
RNA viral infections in Drosophila 
melanogaster. PLoS Biology. 
2008;6(12):e1000002. DOI: 10.1371/
journal.pbio.1000002
[124] Das M. Cardiac arrhythmias in HIV 
disease. Cardiovascular Reviews and 
Reports. 2002;23(4):208-212 +226
[125] Dube MP, Lipshultz SE, 
Fichtenbaum CJ, Greenberg R,  
Schecter AD, Stacy D. Fisher effects 
of HIV infection and antiretroviral 
therapy on the heart and vasculature. 
Circulation. 2008;118:e36e40. DOI: 
10.1161/CIRCULATIONAHA.107.189625
[126] Ocorr K, Reeves NL, Wessells RJ, 
Martin Fink H-S, Chen V, 
Akasaka T, et al. KCNQ potassium 
channel mutations cause cardiac 
arrhythmias in Drosophila that 
mimic the effects of aging. PNAS. 
2007;104(10):3943-3948
[127] Platt GM, Simpson GR, 
Mittnacht S, Schulz TF. Latent nuclear 
antigen of Kaposi's sarcoma-associated 
herpesvirus interacts with RING3, a 
homolog of the Drosophila female 
sterile homeotic (fsh) gene. Journal of 
Virology. 1999;73(12):9789-9795
[128] Geiger JA, Carvalho L, 
Campos I, Santos AC, Jacinto A. Hole-
in-one mutant phenotypes link EGFR/
ERK signaling to epithelial tissue 
repair in Drosophila. PLoS One. 
2011;6(11):e28349. DOI: 10.1371/
journal.pone.0028349
